Patient-Oriented Evidence That Matters
Bedtime Instead of Morning Ingestion of Hypertension Medication Equals a Significantly Higher Reduction in Cardiovascular Disease Risk
June 8, 2020 Editor's Note: This study is under investigation by the editor of the journal in which it was published due to inconsistencies in the data noted by others. Caution is warranted regarding applying these findings to clinical care.
Am Fam Physician. 2020 Apr 1;101(7):434-435.
Does bedtime ingestion instead of morning ingestion of hypertension medications produce better cardiovascular disease risk reduction in adults with hypertension?
This study found a significant reduction in mortality and morbidity among patients who took their once-daily anti-hypertensive medications at bedtime instead of in the morning. No significant difference occurred in compliance rates between bedtime and morning ingestion times. Individual experiences may differ in clinical practice. (Level of Evidence = 1b−)
The investigators identified 19,168 adults, 18 years or older, who met standard criteria for hypertension that required prescription treatment to lower blood pressure (BP). The study participants randomly received (uncertain concealment) assignment to the intervention group or to the control group. The intervention group was told to ingest the entire daily dose of one or more prescribed BP-lowering medications at bedtime. The control group was told to ingest the entire daily dose upon waking. Clinicians provided care without restriction of choice of BP-lowering medication approved for once-daily dosing (e.g., angiotensin receptor blocker, angiotensin-converting enzyme inhibitor, calcium channel blocker, beta blocker, diuretic). Statins, aspirin, and diabetes mellitus medications were also prescribed as needed and ingested as recommended. Individuals masked to treatment group assignment assessed outcomes, including the primary composite outcome of myocardial infarction, coronary revascularization, heart failure, stroke, and cardiovascular disease death. Complete follow-up occurred for more than 99% of participants at a median of 6.3 years.
Using intention-to-treat analysis, significantly fewer patients in the bedtime group experienced the primary cardiovascular disease outcome (n = 1,752 total) compared with the morning group (adjusted hazard ratio = 0.55; 95% CI, 0.50 to 0.61; number needed to treat = 20.3; 95% CI, 17.4 to 24.3).
POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.
For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.
To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.
This series is coordinated by Sumi Sexton, MD, editor-in-chief.
A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.
Want to use this article elsewhere? Get Permissions